在布劳综合征中膜炎的治疗:系统性审查和元分析
Ilaria Maccora1, Carine Wouters2, Carlos D Rosè3
1Neurofarba Department, University of Florence, Italy; Rheumatology division, Meyer Children's Hospital IRCCS, Florence, Italy.
Journal of autoimmunity
|March 27, 2025
概括
系统性治疗显示,在布劳综合征 (BS) 中,尿膜炎的改善率与布劳综合征 (BS) 相似. 目前的证据不足以推这种罕见的自身炎症性疾病的首选疗法,强调需要进一步的研究和指导方针.
科学领域:
- 类风湿病学 类风湿病学
- 眼科医生 眼科 眼科
- 遗传学 遗传学是一种遗传学.
背景情况:
- 布劳综合征 (BS) 是一种罕见的自身炎症性疾病,与NOD2基因变异有关.
- 膀炎是BS的关键特征,如果无法控制,就会造成视力丧失的严重风险.
- 有效的管理策略对于BS相关的脑膜炎至关重要.
研究的目的:
- 系统地审查和元分析布劳综合征中脑膜炎全身治疗的疗效.
- 为了比较常规疾病修饰抗风湿药物 (cDMARDs) 和生物DMARDs (bDMARDs) 在管理BS膜炎的有效性.
主要方法:
- 一个系统的文献审查和元分析,遵循PRISMA指南.
- 纳入标准:报告BS患者接受全身治疗的膜炎的研究和根据膜炎命名标准 (SUN) 标准的疗效数据.
- 分析了11项精选研究中的88种治疗方法.
主要成果:
- 无论是cDMARDs还是bDMARDs,在BS儿童中都显示出类似的脑膜炎改善率 (分别为20%和22%).
- 不同的cDMARDs或bDMARDs之间没有观察到有效性的显著差异.
- 甲托雷克萨特和阿达利穆马布分别是最常用的cDMARD和bDMARD.
结论:
- 目前的证据不足以确定布劳综合征相关的脑膜炎的首选全身治疗方法.
- 由于BS-膜炎的罕见性和潜在严重性,需要对其病理生理学的进一步研究.
- 专家驱动的治疗指南的制定对于管理这种具有挑战性的疾病至关重要.
关键词:
这就是Adalimumab.自发炎性疾病自发炎性疾病.生物药物药物是生物药物.布劳综合症 (Blau Syndrome) 是一种疾病.早期发病的型硬化症.这就是Infliximab.在NOD2中,NOD2是NOD2.泰利多化物是一种治疗方法 治疗方法排卵管炎 排卵管炎 是一种更多相关视频
相关概念视频
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...


